Highlights
NASDAQ: VBLT       Vascular Biogen. Ord
Last Price Today's Change   Day's Range   Trading Volume
1.23   -0.02 (1.60%)  1.20 - 1.265  22,800

Overview

 
Avg Volume (4 weeks):67,957
4 Weeks Range:1.10 - 1.33
4 Weeks Price Volatility (%):
56.52%
52 Weeks Range:0.60 - 1.90
52 Weeks Price Volatility (%):
48.46%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Vascular Biogenics Ltd is an Israel-based clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers